Boehringer Ingelheim Enterprise Account Executive Salaries in Dalton, GA
The average Boehringer Ingelheim Enterprise Account Executive in Dalton, GA earns an estimated $113,451 annually, which includes an estimated base salary of $86,408 with a $27,043 bonus. Boehringer Ingelheim's Enterprise Account Executive compensation is $23 less than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Boehringer Ingelheim in Dalton, GA can range from $52,000 - $205,000.
In Dalton, GA, The Business Development Department at Boehringer Ingelheim earns $5,567 more on average than the Marketing Department.
Last updated 5 months ago.
- $86,408
- avg. base
- $27,043
- avg. bonus
Enterprise Account Executive Salaries at Boehringer Ingelheim
In Dalton, GA, Enterprise Account Executives earn $6,802 more than Account Executives, and $2,844 less than Account Managers.
Compensation at Boehringer Ingelheim by Department
In Dalton, GA, The Business Development Department averages $5,567 more than the Marketing Department, and $2,460 less than the Engineering Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Boehringer Ingelheim reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to Boehringer Ingelheim reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at Boehringer Ingelheim Rate Their Compensation
The majority of Enterprise Account Executives at Boehringer Ingelheim believe they're compensated fairly. The vast majority (72%) of Enterprise Account Executives at Boehringer Ingelheim are satisfied with their benefits. See more compensation ratings at Boehringer Ingelheim
